GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Novo Nordisk A/S (OCSE:NOVO B) » Definitions » Purchase Of Investment

Novo Nordisk A/S (OCSE:NOVO B) Purchase Of Investment : kr-12,088 Mil (TTM As of Mar. 2024)


View and export this data going back to 1993. Start your Free Trial

What is Novo Nordisk A/S Purchase Of Investment?

Novo Nordisk A/S's purchase of investment for the three months ended in Mar. 2024 was kr-1,160 Mil. It means Novo Nordisk A/S spent kr1,160 Mil on purchasing investments. Novo Nordisk A/S's purchase of investment for the trailing twelve months (TTM) ended in Mar. 2024 was kr-12,088 Mil.

Compared with last quarter (kr-948 Mil in Dec. 2023 ), Novo Nordisk A/S spent more money on purchasing investments in Mar. 2024 (kr-1,160 Mil).

Novo Nordisk A/S Purchase Of Investment Historical Data

The historical data trend for Novo Nordisk A/S's Purchase Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novo Nordisk A/S Purchase Of Investment Chart

Novo Nordisk A/S Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Purchase Of Investment
Get a 7-Day Free Trial Premium Member Only Premium Member Only -350.00 - -7,113.00 -9,735.00 -13,289.00

Novo Nordisk A/S Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Purchase Of Investment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2,361.00 -5,149.00 -4,831.00 -948.00 -1,160.00

Novo Nordisk A/S Purchase Of Investment Calculation

Purchase of Investments represents cash outflow on the purchase of investments in securities.

Purchase Of Investment for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-12,088 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Novo Nordisk A/S Purchase Of Investment Related Terms

Thank you for viewing the detailed overview of Novo Nordisk A/S's Purchase Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.

Novo Nordisk A/S (OCSE:NOVO B) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Novo Nordisk A/S (OCSE:NOVO B) » Definitions » Purchase Of Investment
Comparable Companies
OCSE:GMAB OCSE:ZEAL OCSE:ALK B OCSE:BAVA OCSE:GUBRA OCSE:PEG VRTX REGN ASX:CSL MRNA XKRX:207940 XKRX:068270 XBRU:UCB XBRU:ARGX BNTX ALNY BGNE BMRN RPRX SRPT
Traded in Other Exchanges
NONOF:USA NVO:USA NOVOB:Mexico NVO:Mexico NOVOBc:UK 0QIU:UK NOV:Germany N1VO34:Brazil NNO2:Austria
Address
Novo Alle 1, Bagsvaerd, DNK, DK-2880
Website
https://www.novonordisk.com
With roughly one third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (constituting roughly 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.

Novo Nordisk A/S (OCSE:NOVO B) Headlines

No Headlines